Antigen presentation requirements for effective cDC1-based cancer immunotherapy
RNA-seq (gene expression) · mouse · 27 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 27 samples: 9 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE338487_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1494553 and SRA study SRP717658. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 27 samples.
How we read this: 9 replicated groups read from 27 sample titles; they account for 27 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9875540 WT_NS_R1 WT_NS
- GSM9875541 WT_NS_R2 WT_NS
- GSM9875542 WT_NS_R3 WT_NS
- GSM9875543 WT_PIC_R1 WT_PIC
- GSM9875544 WT_PIC_R2 WT_PIC
- GSM9875545 WT_PIC_R3 WT_PIC
- GSM9875546 WT_4PIC_R1 WT_4PIC
- GSM9875547 WT_4PIC_R2 WT_4PIC
- GSM9875548 WT_4PIC_R3 WT_4PIC
- GSM9875549 M1K_NS_R1 M1K_NS
- GSM9875550 M1K_NS_R2 M1K_NS
- GSM9875551 M1K_NS_R3 M1K_NS
- GSM9875552 M1K_PIC_R1 M1K_PIC
- GSM9875553 M1K_PIC_R2 M1K_PIC
- GSM9875554 M1K_PIC_R3 M1K_PIC
- GSM9875555 M1K_4PIC_R1 M1K_4PIC
- GSM9875556 M1K_4PIC_R2 M1K_4PIC
- GSM9875557 M1K_4PIC_R3 M1K_4PIC
- GSM9875558 M2K_NS_R1 M2K_NS
- GSM9875559 M2K_NS_R2 M2K_NS
- GSM9875560 M2K_NS_R3 M2K_NS
- GSM9875561 M2K_PIC_R1 M2K_PIC
- GSM9875562 M2K_PIC_R2 M2K_PIC
- GSM9875563 M2K_PIC_R3 M2K_PIC
- GSM9875564 M2K_4PIC_R1 M2K_4PIC
- GSM9875565 M2K_4PIC_R2 M2K_4PIC
- GSM9875566 M2K_4PIC_R3 M2K_4PIC
- GSE288336 High levels of endogenous Omega-3 Fatty Acids prolong the lifespan, promote antigen presentation, and improve DC-based cancer vaccine efficacy in mice 18 samples shares presentation, antigen
- GSE288801 Chronic Aducanumab-mediated clearance of amyloid plaques decreases microglial activation and induces a unique microglial phenotype associated with antigen presentation 30 samples shares presentation, antigen
- GSE281695 Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration 25 samples shares presentation, antigen
- GSE293728 IFN-γ-STAT1 Axis Drives MHC-II Antigen Presentation Potentiation in Tumor Associated Macrophages 18 samples shares presentation, antigen
- GSE287030 DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation 12 samples shares presentation, antigen
- GSE227998 TET2 Promotes Tumor Antigen Presentation and T Cell-Directed Tumor Cell Cytotoxicity Which is Enhanced by Vitamin C Treatment 12 samples shares presentation, antigen
- GSE269630 Pharmacological Targeting of ALDH1a2 in Dendritic Cells Enhances Antigen Presentation, T Cell Activation and Anti-tumor immunity 10 samples shares presentation, antigen
- GSE168609 MHC class II antigen presentation by tumoral lymphatics is required for tumor specific signature and suppressive functions of Tregs 10 samples shares presentation, antigen
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.